ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses
- 1 March 2004
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 43 (3) , 533-535
- https://doi.org/10.1161/01.hyp.0000118054.86193.ce
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Role of Endothelium-Derived Hyperpolarizing Factor in ACE Inhibitor-Induced Renal Vasodilation in VivoHypertension, 2004
- Contributions of nitric oxide, EDHF, and EETs to endothelium-dependent relaxation in renal afferent arteriolesKidney International, 2003
- Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathiesKidney International, 2003
- Glomerular autacoids stimulated by bradykinin regulate efferent arteriole toneKidney International, 2003
- False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?Hypertension, 2003
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Activation of Gαs Mediates Induction of Tissue-type Plasminogen Activator Gene Transcription by Epoxyeicosatrienoic AcidsJournal of Biological Chemistry, 2001
- Bradykinin attenuates the [Ca2+]i response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHFBritish Journal of Pharmacology, 2001
- Eicosanoid regulation of the renal vasculatureAmerican Journal of Physiology-Renal Physiology, 2000
- Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.Hypertension, 1991